ICMR chief justifies emergency approval citing safety & immunogenicity

Even as the Covid-19 vaccine is likely to arrive in Delhi by early next week, restricted emergency use of vaccines is considered based on safety and immunogenicity data, said Indian Council of Medical Research (ICMR) chief Balram Bhargava. Continue Reading

Expert panel okays Covishield, puts Covaxin on hold

In a huge step towards controlling the spread of the Coronavirus, India on Friday saw an expert panel clearing the Oxford Covid-19 vaccine, manufactured by the Serum Institute of India, even as a dry run of the inoculation programme is to be carried out in the country today. Continue Reading

Covid-19 vaccine: Serum Institute seeks emergency approval

The Serum Institute of India (SII) on Sunday became the first indigenous company to apply to the Drugs Controller General of India (DCGI) seeking emergency use authorisation for the Oxford Covid-19 vaccine in the country. Continue Reading